respiratory syncytial virus-targeting mAb IgG1 nirsevimab [Beyfortus] [107] and severe acute respiratory syndrome coronavirus 2-targeting mix of the IgG1 mAbs tixagevimab cilgavimab [Evusheld] [108, 109]) and blocking activation of the complement cascade to treat the autoimmune disease paroxysmal nocturnal hemoglobinuria (anti-C5 IgG2/4 mAb ravulizumab [Ultomiris] containing the amino acid substitutions M428L/N434S (commonly referred to as LS)) [110]
Infertility and Perinatal Loss: When the Bough Breaks
Liu M, Kuhel DG, Shen L, Hui DY, Woods SC
Reducing the dose means reduced appetite suppression, which can lead to weight regain if eating habits slip
While the company claims the supplement is safe to take with medications, at the very least youll want to ask your healthcare team if your meds should be adjusted
The announcement reflects growing confidence in both the drug's development progress and the commercial potential of obesity treatments globally